Zoetis Inc. - stock earnings
ZTS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 525.0 million USD | 2.2 billion USD |
| 2023Q3 | 596.0 million USD | 2.2 billion USD |
| 2023Q2 | 671.0 million USD | 2.2 billion USD |
| 2023Q1 | 552.0 million USD | 2.0 billion USD |
| 2022Q4 | 461.0 million USD | 2.0 billion USD |
| 2022Q3 | 529.0 million USD | 2.0 billion USD |
| 2022Q2 | 529.0 million USD | 2.1 billion USD |
| 2022Q1 | 595.0 million USD | 2.0 billion USD |
| 2021Q4 | 414.0 million USD | 2.0 billion USD |
| 2021Q3 | 552.0 million USD | 2.0 billion USD |
| 2021Q2 | 512.0 million USD | 1.9 billion USD |
| 2021Q1 | 559.0 million USD | 1.9 billion USD |
| 2020Q4 | 359.0 million USD | 1.8 billion USD |
| 2020Q3 | 479.0 million USD | 1.8 billion USD |
| 2020Q2 | 377.0 million USD | 1.5 billion USD |
| 2020Q1 | 423.0 million USD | 1.5 billion USD |
| 2019Q4 | 384.0 million USD | 1.7 billion USD |
| 2019Q3 | 433.0 million USD | 1.6 billion USD |
| 2019Q2 | 371.0 million USD | 1.5 billion USD |
| 2019Q1 | 312.0 million USD | 1.5 billion USD |
| 2018Q4 | 345.0 million USD | 1.6 billion USD |
| 2018Q3 | 347.0 million USD | 1.5 billion USD |
| 2018Q2 | 384.0 million USD | 1.4 billion USD |
| 2018Q1 | 352.0 million USD | 1.4 billion USD |
| 2017Q4 | 81.0 million USD | 1.5 billion USD |
| 2017Q3 | 298.0 million USD | 1.3 billion USD |
| 2017Q2 | 247.0 million USD | 1.3 billion USD |
| 2017Q1 | 238.0 million USD | 1.2 billion USD |
| 2016Q4 | 154.0 million USD | 1.3 billion USD |
| 2016Q3 | 239.0 million USD | 1.2 billion USD |
| 2016Q2 | 224.0 million USD | 1.2 billion USD |
| 2016Q1 | 204.0 million USD | 1.2 billion USD |
| 2015Q4 | 22.0 million USD | 1.3 billion USD |
| 2015Q3 | 189.0 million USD | 1.2 billion USD |
| 2015Q2 | -37.0 million USD | 1.2 billion USD |
| 2015Q1 | 165.0 million USD | 1.1 billion USD |
| 2014Q4 | 126.0 million USD | 1.3 billion USD |
| 2014Q3 | 166.0 million USD | 1.2 billion USD |
| 2014Q2 | 136.0 million USD | 1.2 billion USD |
| 2014Q1 | 155.0 million USD | 1.1 billion USD |
| 2013Q4 | 105.0 million USD | 1.3 billion USD |
| 2013Q3 | 131.0 million USD | 1.1 billion USD |
| 2013Q2 | 128.0 million USD | 1.1 billion USD |
| 2013Q1 | 140.0 million USD | 1.1 billion USD |
| 2012Q4 | -10.0 million USD | 1.2 billion USD |
| 2012Q3 | 162.0 million USD | 1.0 billion USD |
| 2012Q2 | 173.0 million USD | 1.1 billion USD |
| 2012Q1 | 111.0 million USD | 1.0 billion USD |
| 2011Q4 | 9.0 million USD | 1.1 billion USD |
| 2011Q3 | 94.0 million USD | 1.0 billion USD |
| 2011Q2 | 66.0 million USD | 1.1 billion USD |
| 2011Q1 | 76.0 million USD | 983.0 million USD |
| 2010Q4 | 110.0 million USD | 3.6 billion USD |
ZTS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 2.3 billion USD | 8.5 billion USD |
| 2022 | 2.1 billion USD | 8.1 billion USD |
| 2021 | 2.0 billion USD | 7.8 billion USD |
| 2020 | 1.6 billion USD | 6.7 billion USD |
| 2019 | 1.5 billion USD | 6.3 billion USD |
| 2018 | 1.4 billion USD | 5.8 billion USD |
| 2017 | 864.0 million USD | 5.3 billion USD |
| 2016 | 821.0 million USD | 4.9 billion USD |
| 2015 | 339.0 million USD | 4.8 billion USD |
| 2014 | 583.0 million USD | 4.8 billion USD |
| 2013 | 504.0 million USD | 4.6 billion USD |
| 2012 | 436.0 million USD | 4.3 billion USD |
| 2011 | 245.0 million USD | 4.2 billion USD |
| 2010 | 110.0 million USD | 3.6 billion USD |
| 2009 | -100.0 million USD | 2.8 billion USD |
ZTS
List: Contenders
Price: $157.21
Dividend Yield: 0.01%
Forward Dividend Yield: 1.13%
Payout Ratio: 35.19%
Dividend Per Share: 1.73 USD
Earnings Per Share: 5.07 USD
P/E Ratio: 38.08
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 1.6 million
Ebitda: 543.0 millionMarket Capitalization: 68.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 12
DGR3: 18.80%
DGR5: 19.52%
DGR10: 16.63%